Howard McLeod, Geoffrey Harris
Cancer Genetics has added Howard McLeod and Geoffrey Harris to its board of directors.
McLeod is the medical director of the DeBartolo Family Personalized Medicine Institute at the Moffitt Cancer Center. He joined Moffitt last year from the University of North Carolina's Institute for Pharmacogenomics and Individualized Therapy, of which he was the founding director.
Harris is a portfolio manager and managing partner at c7 Advisors, a healthcare advisory firm. Before c7 Advisors, Harris was managing director and co-head of the Cantor Fitzgerald Healthcare Investment Group from 2011 to 2014.